{"id":18875,"date":"2019-09-12T07:53:34","date_gmt":"2019-09-12T07:53:34","guid":{"rendered":"https:\/\/thepatientinvestor.com\/?p=18875"},"modified":"2022-05-20T06:40:18","modified_gmt":"2022-05-20T06:40:18","slug":"telstra-corp-ltd-tls","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/","title":{"rendered":"Telstra Corp Ltd (TLS)"},"content":{"rendered":"\n\n\n\n\n\n\n\n\n\n
Stock:<\/td>\nTelstra Corp Ltd<\/strong><\/td>\n<\/tr>\n
Exchange:<\/td>\nASX<\/td>\nSymbol:<\/td>\nTLS<\/strong><\/td>\n<\/tr>\n
Date:<\/td>\nSeptember 12, 2019<\/td>\nLatest price:<\/td>\n$3.59<\/strong> AUD<\/td>\n<\/tr>\n
Market Cap:<\/td>\n$42.9 bn<\/td>\nFair Value Estimate:<\/td>\n$3.83<\/strong><\/td>\n<\/tr>\n
Forward P\/E:<\/td>\n16.6<\/td>\nFair Value Payback:<\/td>\n13 Years<\/td>\n<\/tr>\n
Financial Y\/E:<\/td>\n30 June<\/td>\nRating:<\/td>\nHold<\/strong><\/td>\n<\/tr>\n
Sector:<\/td>\nCommunications Services<\/td>\nIndustry:<\/td>\nTelecom Services<\/td>\n<\/tr>\n
Investment Theme:<\/td>\nDividends & Growth<\/td>\nForward Dividend Yield<\/td>\n2.81% (fully franked)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Summary<\/h2>\n

Telstra is a defensive stock with dominant market share in mobile, broadband and the rapidly shrinking fixed line market.<\/p>\n

We assign a fair value of $3.83 based on an EBITDA of $7.7 billion (net of $3 billion hole from NBN roll-out less $1.3 billion in expected cost savings), 4% long-term growth, $10.7 billion compensation from the NBN rollout (net of expected future redundancy costs), a 10% margin of safety and a 13 year payback period.<\/p>\n

Telstra would not be suitable for international investors who cannot take advantage of franking credits on dividends.<\/p>\n

Our current rating is HOLD because of the correction on the chart below. We plan to upgrade this to BUY if Trend Index (13-week) forms a trough above zero.<\/p>\n

Recommended portfolio weighting is 5% of portfolio value.<\/p>\n

Technical Analysis<\/h2>\n

Telstra is currently undergoing a correction after an impressive rally since the start of 2019. We expect the correction to find support at $3.20. A Trend Index trough above zero would indicate buying pressure.<\/p>\n

\"Twiggs<\/p>\n

Company Profile<\/h2>\r\n

Telstra is the largest player in the Australian telecommunications industry and owns and operates an extensive telecommunications network. Telstra markets voice, mobile, broadband and pay television (35% of Foxtel) and enjoys strong brand recognition. They boast the widest mobile coverage and jealously guard competitor access to their network.<\/p>\r\n

Competitors & Markets<\/h3>\r\n

Optus (a subsidiary of SingTel) competes mainly in mobile, broadband and voice. It owns and operates its own network but also uses the wholesale services of the NBN and Telstra. Optus was making inroads in the broadband and mobile markets, bundling services with free sports coverage of the 2018 Soccer World Cup, but this led to an embarrassing failure when their network proved incapable of handling the traffic volume.<\/p>\r\n\r\n

TPG Telecom Ltd (TPM) is an Australian telecommunications company and one of the fastest growing domestic Internet service providers in Australia. Under the TPG, AAPT and iiNet brands, the group enjoys a 26% share of the Australian broadband subscriber market (or 1.9 million subscribers). Margins have suffered as migration to the NBN grows.<\/p>\r\n\r\n

TPG proposed a merger with third mobile network provider Vodafone but this has so far been blocked by the Australian Competition and Consumer Commission (ACCC) on the grounds that the merger would lessen competition between mobile players. Vodafone has appealed the decision.<\/p>\r\n

The ACCC found that TPG would have the capacity to roll out a new 4G mobile network in the coming years and therefore allowing the two parties to merge would remove this additional competitor from the market. TPG\u2019s counsel Ruth Higgins told the court that TPG's ability to build a 4G network was already outdated with new 5G technology. \"5G isn't just a possibility. It's a product.\" (The Age<\/a>)<\/p><\/blockquote>\r\n

TPG is the second biggest player in fixed broadband and Vodafone ranks third in mobile. A deal would leverage Vodafone's existing underutilized mobile network and save TPG on infrastructure spending. A combined entity would still rank third in mobile but would be more able to compete with Telstra and Optus in the 5G market, spreading the large capital costs over a broader subscriber base.<\/p>\r\n

5G Wireless Network<\/h3>\r\n

Extensive capital outlays required to implement 5G are only within the means of the largest players. Telstra's choice of Ericsson as its major 5G supplier has given them an advantage over Optus who had tied up with Huawei before the Australian government banned them from supplying 5G equipment:<\/p>\r\n

Australia's secretary for foreign affairs and trade said her government's guidance to keep equipment from Chinese makers Huawei Technologies and ZTE out of 5G wireless networks was made after national security risks were assessed from \"all possible angles.\" (Nikkei Asian Review<\/a>)<\/p><\/blockquote>\r\n

Why Invest in Telecommunications?<\/h3>\r\n

The Australian telecommunications industry has gone through a torrid time in the past two years, with disruption from the National Broadband Network (NBN) eroding the competitive advantage of larger players and consequently margins. The ASX 300 Telecommunications Index fell more than 56% between 2015 and 2018.<\/p>\r\n\r\n\"ASX\r\n\r\n

The Australian telecom industry occupies a unique defensive position. The industry is dominated by a few players, with low threat of competition from offshore because of the massive infrastructure investment required and high existing levels of penetration in a mature market.<\/p>\r\n\r\n

Total number of broadband subscribers increased to 14.21 million in December 2017 from 13.64 m a year earlier (ABS<\/a>), a growth rate of 4.2%. But data usage is growing exponentially, with downloads up by 38.6% to 3.6 million Terabytes (TB).<\/p>\r\n\r\n\"Australian\r\n\r\n

Source: ABS<\/a><\/em><\/p>\r\n\r\n

Mobile usage shows a similar pattern with subscribers up by 4.9% to 26.7 million by December 2017, while data downloads increased by 39.1%.<\/p>\r\n\r\n

Structural trends show promise, with online services and the Internet of things<\/em> \u2014 rising connectivity across devices from motor vehicles to television sets and refrigerators \u2014 expected to grow exponentially.<\/p>\r\n\r\n

Wireless and mobile data usage are small (9%) compared to fixed line broadband but that is expected to change. Telstra has commenced roll-out of the 5G network which offers data rates of several tens of Mb\/s and supports hundreds of thousands of simultaneous connections required for massive sensor deployments under the Internet of things<\/em>.<\/p><\/div>\n

Disclosure<\/h4>\n

Staff of The Patient Investor may directly or indirectly own shares in the above company.<\/p>\n","protected":false},"excerpt":{"rendered":"

Stock: Telstra Corp Ltd Exchange: ASX Symbol: TLS Date: September 12, 2019 Latest price: $3.59 AUD Market Cap: $42.9 bn Fair Value Estimate: $3.83 Forward P\/E: 16.6 Fair Value Payback: 13 Years Financial Y\/E: 30 June Rating: Hold Sector: Communications Services Industry: Telecom Services Investment Theme: Dividends & Growth Forward Dividend Yield 2.81% (fully franked) … <\/p>\n

Continue reading “Telstra Corp Ltd (TLS)”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3799],"tags":[4114,4115],"class_list":["post-18875","post","type-post","status-publish","format-standard","hentry","category-asx-growth","tag-telstra-corp-ltd","tag-tls"],"yoast_head":"\nTelstra Corp Ltd (TLS) - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Telstra Corp Ltd (TLS) - the patient investor\" \/>\n<meta property=\"og:description\" content=\"Stock: Telstra Corp Ltd Exchange: ASX Symbol: TLS Date: September 12, 2019 Latest price: $3.59 AUD Market Cap: $42.9 bn Fair Value Estimate: $3.83 Forward P\/E: 16.6 Fair Value Payback: 13 Years Financial Y\/E: 30 June Rating: Hold Sector: Communications Services Industry: Telecom Services Investment Theme: Dividends & Growth Forward Dividend Yield 2.81% (fully franked) … Continue reading "Telstra Corp Ltd (TLS)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:author\" content=\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-12T07:53:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-20T06:40:18+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/static.incrediblecharts.com\/images\/2018\/2019-09-12-tls.png\" \/>\n<meta name=\"author\" content=\"Colin Twiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Colin Twiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2019\\\/09\\\/12\\\/telstra-corp-ltd-tls\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2019\\\/09\\\/12\\\/telstra-corp-ltd-tls\\\/\"},\"author\":{\"name\":\"Colin Twiggs\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/d42b18d516a80149d739845749ac6454\"},\"headline\":\"Telstra Corp Ltd (TLS)\",\"datePublished\":\"2019-09-12T07:53:34+00:00\",\"dateModified\":\"2022-05-20T06:40:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2019\\\/09\\\/12\\\/telstra-corp-ltd-tls\\\/\"},\"wordCount\":234,\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2019\\\/09\\\/12\\\/telstra-corp-ltd-tls\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2018\\\/2019-09-12-tls.png\",\"keywords\":[\"Telstra Corp Ltd\",\"TLS\"],\"articleSection\":[\"Australian Growth\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2019\\\/09\\\/12\\\/telstra-corp-ltd-tls\\\/\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2019\\\/09\\\/12\\\/telstra-corp-ltd-tls\\\/\",\"name\":\"Telstra Corp Ltd (TLS) - the patient investor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2019\\\/09\\\/12\\\/telstra-corp-ltd-tls\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2019\\\/09\\\/12\\\/telstra-corp-ltd-tls\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2018\\\/2019-09-12-tls.png\",\"datePublished\":\"2019-09-12T07:53:34+00:00\",\"dateModified\":\"2022-05-20T06:40:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2019\\\/09\\\/12\\\/telstra-corp-ltd-tls\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2019\\\/09\\\/12\\\/telstra-corp-ltd-tls\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2019\\\/09\\\/12\\\/telstra-corp-ltd-tls\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2018\\\/2019-09-12-tls.png\",\"contentUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2018\\\/2019-09-12-tls.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2019\\\/09\\\/12\\\/telstra-corp-ltd-tls\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/thepatientinvestor.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Telstra Corp Ltd (TLS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/thepatientinvestor.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61572934660810\",\"https:\\\/\\\/www.instagram.com\\\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/d42b18d516a80149d739845749ac6454\",\"name\":\"Colin Twiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"caption\":\"Colin Twiggs\"},\"description\":\"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\\\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.\",\"sameAs\":[\"https:\\\/\\\/facebook.com\\\/people\\\/The-Patient-Investor\\\/61572934660810\\\/\",\"https:\\\/\\\/www.instagram.com\\\/colin_thepatientinvestor\",\"https:\\\/\\\/au.linkedin.com\\\/in\\\/colintwiggs\"],\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/author\\\/investor\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Telstra Corp Ltd (TLS) - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Telstra Corp Ltd (TLS) - the patient investor","og_description":"Stock: Telstra Corp Ltd Exchange: ASX Symbol: TLS Date: September 12, 2019 Latest price: $3.59 AUD Market Cap: $42.9 bn Fair Value Estimate: $3.83 Forward P\/E: 16.6 Fair Value Payback: 13 Years Financial Y\/E: 30 June Rating: Hold Sector: Communications Services Industry: Telecom Services Investment Theme: Dividends & Growth Forward Dividend Yield 2.81% (fully franked) … Continue reading \"Telstra Corp Ltd (TLS)\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_author":"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","article_published_time":"2019-09-12T07:53:34+00:00","article_modified_time":"2022-05-20T06:40:18+00:00","og_image":[{"url":"http:\/\/static.incrediblecharts.com\/images\/2018\/2019-09-12-tls.png","type":"","width":"","height":""}],"author":"Colin Twiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Colin Twiggs","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/"},"author":{"name":"Colin Twiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454"},"headline":"Telstra Corp Ltd (TLS)","datePublished":"2019-09-12T07:53:34+00:00","dateModified":"2022-05-20T06:40:18+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/"},"wordCount":234,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/2019-09-12-tls.png","keywords":["Telstra Corp Ltd","TLS"],"articleSection":["Australian Growth"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/","name":"Telstra Corp Ltd (TLS) - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/2019-09-12-tls.png","datePublished":"2019-09-12T07:53:34+00:00","dateModified":"2022-05-20T06:40:18+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/#primaryimage","url":"https:\/\/www.incrediblecharts.com\/images\/2018\/2019-09-12-tls.png","contentUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/2019-09-12-tls.png"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/09\/12\/telstra-corp-ltd-tls\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Telstra Corp Ltd (TLS)"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454","name":"Colin Twiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","caption":"Colin Twiggs"},"description":"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.","sameAs":["https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","https:\/\/www.instagram.com\/colin_thepatientinvestor","https:\/\/au.linkedin.com\/in\/colintwiggs"],"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-4Ur","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":38356,"url":"https:\/\/thepatientinvestor.com\/index.php\/2022\/10\/27\/telstra-tls-2\/","url_meta":{"origin":18875,"position":0},"title":"Telstra (TLS)","author":"Colin Twiggs","date":"October 27, 2022","format":false,"excerpt":"Stock: Telstra Exchange: ASX Symbol: TLS\/TLSDA* Date: 27-Oct-22 Latest price: A$3.85 Market Cap: A$44.5 bn Fair Value: A$3.94 Forward DY: 3.9% Payback (Years): 13 Financial Y\/E: 30-Jun-23 Rating: HOLD Sector: Technology Industry: Communications Investment Theme: Dividends & Growth Macro Trends: Defensive *Telstra is trading under deferred settlement, with the temporary\u2026","rel":"","context":"In "Australian Growth"","block_context":{"text":"Australian Growth","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investment-allocation\/asx-growth\/"},"img":{"alt_text":"TGL Structure","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2022\/2022-10-27-tgl-structure.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2022\/2022-10-27-tgl-structure.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2022\/2022-10-27-tgl-structure.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":36910,"url":"https:\/\/thepatientinvestor.com\/index.php\/2022\/08\/25\/telstra-tls\/","url_meta":{"origin":18875,"position":1},"title":"Telstra (TLS)","author":"Colin Twiggs","date":"August 25, 2022","format":false,"excerpt":"Telstra (TLS) is Australia\u2019s largest telecommunications provider, with strong market share in voice, mobile, data and internet, across retail, corporate and wholesale markets. The group has four segments: Consumer & Small Business provides mobile and fixed line telecommunications to the retail market; Enterprise provides telecommunications, networking, cloud and security to\u2026","rel":"","context":"In "Australian Growth"","block_context":{"text":"Australian Growth","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investment-allocation\/asx-growth\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":19395,"url":"https:\/\/thepatientinvestor.com\/index.php\/2019\/11\/15\/australian-growth-performance-at-31-october-2019\/","url_meta":{"origin":18875,"position":2},"title":"Australian Growth: Performance at 31 October 2019","author":"Andy","date":"November 15, 2019","format":false,"excerpt":"Australian Growth portfolio performance since inception on 1 July 2018 is set out below. This is too short a period to give a real indication as to how the portfolio will perform in the long-term: we expect to hold most growth stocks for 5 to 10 years. Performance of Individual\u2026","rel":"","context":"In "Australian Growth Performance"","block_context":{"text":"Australian Growth Performance","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investment-allocation\/australian-growth-performance\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2019\/11\/australian-performance-bystock-20191031_1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2019\/11\/australian-performance-bystock-20191031_1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2019\/11\/australian-performance-bystock-20191031_1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2019\/11\/australian-performance-bystock-20191031_1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2019\/11\/australian-performance-bystock-20191031_1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2019\/11\/australian-performance-bystock-20191031_1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":16866,"url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/08\/24\/tpg-telecom-ltd-tpm-double-bottom-but-high-risk\/","url_meta":{"origin":18875,"position":3},"title":"TPG Telecom Ltd (TPM) – Double bottom but high risk","author":"Colin Twiggs","date":"August 24, 2018","format":false,"excerpt":"Stock: TPG Telecom Ltd Symbol: TPM Exchange: ASX Financial Year-end: 31 July Latest price: $7.72 Date: August 24, 2018 Sector: Communications Industry: Telecom Services Investment Theme: Structural Trends TPG is positioned to benefit from the rise of technology, with rapid long-term growth in the communications sector. Company Profile TPG is\u2026","rel":"","context":"In "Australia & NZ"","block_context":{"text":"Australia & NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":24515,"url":"https:\/\/thepatientinvestor.com\/index.php\/2021\/03\/12\/australian-growth-performance-at-28-february-2021\/","url_meta":{"origin":18875,"position":4},"title":"Australian Growth: Performance at 28 February 2021","author":"Andy","date":"March 12, 2021","format":false,"excerpt":"Australian Growth portfolio performance since inception on 1 July 2018 is set out below. We expect to hold most growth stocks for 5 to 10 years. Individual Stocks Notes: Performance is calculated in Australian Dollars. Annualized performance is calculated using the CAGR formula. Returns are calculated after brokerage costs but\u2026","rel":"","context":"In "Australian Growth Performance"","block_context":{"text":"Australian Growth Performance","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investment-allocation\/australian-growth-performance\/"},"img":{"alt_text":"Australian Growth Annualized Performance 1-Jul-2018 to 28-Feb-2021: Portfolio 4.49%, ASX 200 Accumulation Index 6.73%","src":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2021\/03\/perf-2021-02-aus.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2021\/03\/perf-2021-02-aus.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2021\/03\/perf-2021-02-aus.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":25387,"url":"https:\/\/thepatientinvestor.com\/index.php\/2021\/04\/22\/australian-growth-performance-at-31-march-2021\/","url_meta":{"origin":18875,"position":5},"title":"Australian Growth: Performance at 31 March 2021","author":"Andy","date":"April 22, 2021","format":false,"excerpt":"Australian Growth portfolio performance since inception on 1 July 2018 is set out below. We expect to hold most growth stocks for 5 to 10 years. Individual Stocks The portfolio has a sizable allocation to gold & precious metals (17% at 31-Mar-2021).\u00a0 We expect rising inflation and negative real interest\u2026","rel":"","context":"In "Australian Growth Performance"","block_context":{"text":"Australian Growth Performance","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investment-allocation\/australian-growth-performance\/"},"img":{"alt_text":"Australian Growth Annualized Performance 1-Jul-2018 to 31-Mar-2021: Portfolio 4.83%, ASX 200 Accumulation Index 7.46%","src":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2021\/04\/perf-2021-03-aus.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2021\/04\/perf-2021-03-aus.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2021\/04\/perf-2021-03-aus.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/18875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=18875"}],"version-history":[{"count":6,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/18875\/revisions"}],"predecessor-version":[{"id":33221,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/18875\/revisions\/33221"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=18875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=18875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=18875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}